1. Home
  2. KYMR vs RYN Comparison

KYMR vs RYN Comparison

Compare KYMR & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$83.62

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$20.70

Market Cap

6.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
RYN
Founded
2015
1926
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.1B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
KYMR
RYN
Price
$83.62
$20.70
Analyst Decision
Strong Buy
Buy
Analyst Count
26
4
Target Price
$107.72
$26.00
AVG Volume (30 Days)
575.0K
2.7M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
11.98%
EPS Growth
N/A
26.78
EPS
N/A
3.03
Revenue
$39,211,000.00
$484,485,000.00
Revenue This Year
$11.85
$214.96
Revenue Next Year
$7.79
$10.35
P/E Ratio
N/A
$6.87
Revenue Growth
N/A
N/A
52 Week Low
$19.45
$19.49
52 Week High
$103.00
$27.34

Technical Indicators

Market Signals
Indicator
KYMR
RYN
Relative Strength Index (RSI) 54.10 47.50
Support Level $77.78 $19.49
Resistance Level $95.90 $22.37
Average True Range (ATR) 3.76 0.44
MACD 0.70 0.16
Stochastic Oscillator 76.54 72.46

Price Performance

Historical Comparison
KYMR
RYN

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

Share on Social Networks: